Literature DB >> 6801913

Increase in noradrenaline-synthesizing enzyme activity in medulla oblongata in Parkinson's disease.

N Kopp, L Denoroy, M Tommasi, N Gay, G Chazot, B Renaud.   

Abstract

Dopamine beta hydroxylase (DBH), The noradrenaline-synthesizing enzyme, and phenyl-ethanolamine-N-methyltransferase (PNMT), the adrenaline-synthesizing enzyme, were assayed in 18 areas of brain stem in eight cases of parkinsonian syndromes and of four age- and postmortem delay-matched controls. Dissection was performed by the "punch" technique and enzyme activities assayed by radiometric methods. No significant change was found for PNMT activity. DBH activity was significantly increased in the A2-C2 area of the medulla oblongata (including the nucleus tractus solitarius) in the cases of Parkinson's disease. The A2-C2 area is known to be implicated in the control of blood pressure in rats. These findings are discussed in relation to orthostatic hypotension and the influence of L-dopa therapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801913     DOI: 10.1007/BF00691177

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  Physiological control of brain catechol synthesis by brain tyrosine concentration.

Authors:  C J Gibson; R J Wurtman
Journal:  Biochem Pharmacol       Date:  1977-06-15       Impact factor: 5.858

2.  Tyrosine administration reduces blood pressure and enhances brain norepinephrine release in spontaneously hypertensive rats.

Authors:  A F Sved; J D Fernstrom; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

3.  Early increase in phenylethanolamine-N-methyltransferase activity in a new strain of spontaneously hypertensive rats.

Authors:  B Renaud; S Fournière; L Denoroy; M Vincent; J F Pujol; J Sassard
Journal:  Brain Res       Date:  1978-12-22       Impact factor: 3.252

4.  Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain.

Authors:  T Nagatsu; T Kato; Y Numata; K Ikuta; M Sano
Journal:  Clin Chim Acta       Date:  1977-03-01       Impact factor: 3.786

5.  Adrenaline-forming enzyme in brainstem: elevation in genetic and experimental hypertension.

Authors:  J M Saavedra; H Grobecker; J Axelrod
Journal:  Science       Date:  1976-02-06       Impact factor: 47.728

6.  Dihydralazine and catecholamine-synthesizing enzymes in spontaneous hypertension.

Authors:  L Denoroy; B Renaud; M Vincent; J Sacquet; J Sassard
Journal:  Eur J Pharmacol       Date:  1979-09-15       Impact factor: 4.432

Review 7.  NIH conference. Dopamine- -hydroxylase. Basic and clinical studies.

Authors:  I J Kopin; S Kaufman; H Viveros; D Jacobowitz; C R Lake; M G Ziegler; W Lovenberg; F K Goodwin
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391

8.  Distribution of adrenaline-synthesizing enzyme activity in the human brain.

Authors:  N Kopp; L Denoroy; B Renaud; J F Pujol; A Tabib; M Tommasi
Journal:  J Neurol Sci       Date:  1979-05       Impact factor: 3.181

9.  Normal plasma dopamine-beta-hydroxylase in non-treated and treated Parkinson patients.

Authors:  M Markianos; M Hadjikonstantinou; C Sfagos
Journal:  Acta Neurol Scand       Date:  1981-04       Impact factor: 3.209

10.  Plasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading.

Authors:  J Vardi; S Flechter; Z Oberman; M Allelov; J M Rabey; M Hertzberg; M Streifler
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

View more
  4 in total

1.  Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.

Authors:  A Churchyard; C J Mathias; P Boonkongchuen; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

2.  DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.

Authors:  W Birkmayer; G Birkmayer; H Lechner; P Riederer
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

Review 3.  The hypothalamus in Parkinson disease.

Authors:  R Sandyk; R P Iacono; C R Bamford
Journal:  Ital J Neurol Sci       Date:  1987-06

4.  DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis.

Authors:  Dominik Piston; Lydia Alvarez-Erviti; Vikas Bansal; Daniela Gargano; Zhi Yao; Gyorgy Szabadkai; Mark Odell; M Rhyan Puno; Benny Björkblom; Jodi Maple-Grødem; Peter Breuer; Oliver Kaut; Jan Petter Larsen; Stefan Bonn; Simon Geir Møller; Ullrich Wüllner; Anthony H V Schapira; Matthew E Gegg
Journal:  Hum Mol Genet       Date:  2017-10-15       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.